APA (7th ed.) Citation

A, B., SM, T., VK, G., X, C., F, Y., W, C., . . . JA, S. (2026). Economic value of ribociclib in early breast cancer in the United States. Journal of managed care & specialty pharmacy, 32(8), 911. https://doi.org/10.18553/jmcp.2026.32.8.911

Chicago Style (17th ed.) Citation

A, Brufsky, et al. "Economic Value of Ribociclib in Early Breast Cancer in the United States." Journal of Managed Care & Specialty Pharmacy 32, no. 8 (2026): 911. https://doi.org/10.18553/jmcp.2026.32.8.911.

MLA (9th ed.) Citation

A, Brufsky, et al. "Economic Value of Ribociclib in Early Breast Cancer in the United States." Journal of Managed Care & Specialty Pharmacy, vol. 32, no. 8, 2026, p. 911, https://doi.org/10.18553/jmcp.2026.32.8.911.